Fluidigm Corporation, a Delaware Corporation v. Ionpath, Inc., a Delaware Corporation
United States District Court, Northern District of CaliforniaOctober 9, 20203:19-cv-05639California1,893 words
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT
NORTHERN DISTRICT OF CALIFORNIA
FLUIDIGM CORPORATION, et al., Plaintiffs, No. C 19-05639 WHA
v.
IONPATH, INC., ORDER DENYING LEAVE TO FILE
THIRD AMENDED COMPLAINT
Defendant.
13 INTRODUCTION In this patent and business interference suit, patent owner seeks leave to amend its complaint for the third time to add a claim under the Lanham Act. This order does not reach the merits of the proposed pleading, however, as patent owner failed to diligently investigate the facts that it says gave rise to this new claim. The motion is DENIED. STATEMENT Prior orders detail the facts here (Dkt. Nos. 46, 58). In brief, patent owner, Fluidigm Corporation and Fluidigm Canada Inc., markets mass cytometry methods and systems for cell structure and biomarker analysis. The methods involve labelling a sample, usually a cell or tissue suspension, with metal tags attached to antibodies in a process called “staining.”…